Home/Pipeline/Intranasal Delivery System (Partnered)

Intranasal Delivery System (Partnered)

Not Specified (via SPONTAN®)

Phase 2Active

Key Facts

Indication
Not Specified (via SPONTAN®)
Phase
Phase 2
Status
Active
Company

About MOD3 Pharma

MOD3 Pharma is a private, pre-revenue biotech firm founded in 2018 and based in San Diego, specializing in advanced drug delivery systems. The company's platform includes precision dosing technologies, notably intranasal delivery systems, which are already being utilized by partners in Phase II clinical trials for respiratory conditions. While specific pipeline details are not publicly disclosed, its business model is centered on partnering with pharmaceutical companies to enable next-generation therapeutic administration.

View full company profile

Therapeutic Areas